AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...

Content from other channels on our network

Could this tailored heart pump transform care for half of heart failure patients?

Monash University tailored heart pump — laboratory set-up

Minderoo Children's Comprehensive Cancer Centre, Randwick

Hospital fined $230K after aged care chair detachment

Helping to keep health care professionals hands-on

Four food safety tips for the silly season

Santa creates a spike in Australia's milk demand

Spicing up the festive season with Australian bushfood flavours

Kraft Heinz appoints Steve Cahillane as CEO

Irish drinks manufacturer takes its supply chain to the next level

Sustainability in 2026: what's next for Australian businesses?

How Australia can increase its circularity rate

$25m grant supports cleaner cement production

Bürkert team to take on sustainability strategies

ASC certifies NT barramundi farm